2025-02-042025-02-052025-02-04https://hdl.handle.net/11420/53959The KiMeKo partners have acquired many skills in previous KI-Med projects - in particular KI-SIGS funded by the BMWK and KI-Lab funded by the BMBF - but these are decentralized, unsystematized and in need of supplementation. This is precisely the aim of the five KIMKO sub-projects: to bundle and deepen expertise in such a way that the KI-Med ecosystem can offer standardized services, i.e. methods, tools and workflows, as far as possible. On this basis, the AI-Med collaboration platform is intended to ensure that, on the one hand, the collaboration between medical professionals, IT specialists and companies (the stakeholder groups), which is essential for AI-Med applications, is made significantly more efficient (faster and qualitatively improved); in order to implement larger - possibly also disruptive - strategic AI-Med applications with truly broad usage potential in healthcare with a higher chance of success. And on the other hand, the aim is to accelerate the development of such AI-Med innovations to such an extent that AI-Med medical products can actually be developed with regulatory approval, which alone find their way into healthcare and thus enable economic value creation in the healthcare system and for companies. The five sub-projects are all being carried out by the universities' IT institutes with the advisory involvement of clinics and companies, as the intention is not yet to develop AI-Med applications as such, but to create the strong conditions that will enable them to scale in the context of the AI-Med ecosystem in the future.